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It Was previously found in this laboratory
that antibody levels to Corynebacterium ccnes
are higher in serum from patients with acne
than in serum from healthy controls (1, 2).
This suggested that a hypersensitivity reac-
tion to C. acnes may be involved in the patho-
genesis of acne vulgaris.
The work described in this paper attempted
to establish in patients with acne vulgaris the
degree of dcrmal hypersensitivity to antigens
prepared from C. acnes. TWO different antigens
were used. Both reacted strongly in in. vitro
serologic tests With hyperimmune rabbit serum
to C. ccnes. Subjects for the study were volun-
teers from a prison population at the Cali-
fornia Institution for Women at Frontera,
California.t
MATERIAL5 ANn METHOn5
Skin testing antigens. (a) Disrupted cntigen:
Disrupted antigen was prepared in the same way
as that described previously for the production of
antigen for the complement-fixation test for anti-
bodies to C. canes (2). C. ccnes ATCC strain 11827
was grown in Bacto Brain Heart Infosion broth
supplemented with 2% dextrose (Difco) and 0.1%
sodium thioglycollate (Difco). Cultures were har-
vested by centrifugation and washed four times
with sterile distilled water. Cells wore disrupted by
rapid homogenization in the presence of minute
glass beads (Ballotini) in a Virtis homogenizer
(Model 45). The suspension of disrupted organisms
was separated from the glass beads by filtration
through a Whatman No. 1 filter paper, and lyophi-
lized. The lyophihzed material was weighed, and a
one percent (w/v) suspension prepared using buff-
ered (pH 72) pbysiologic saline. This suspension
was sterilized by the addition of 4% phenol for
four days at 4° C. The antigen was tested for
sterility on blood agar aerobically and anaerobi-
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cally, Sabouraud dextrose agar (Difco) and thio-
glycollate broth (Difco). Sterile 1% antigen was
further diluted 1.0, 50, 100 and 1000 times with
buffered saline, making antigns of 1:1000, 1:5000,
1:10,000 and 1:100,000 concentrations (i.e. gm/mi).
Five ml samples of each dilution were stored in
sterile rubber tipped vials at 4° C.
(b) Diolysed antigen was prepared from a
growth filtrate of C. acnes ATCC strain 11827. The
organisms were grown for 21 days at 37° C in 50
ml amounts of physiologic saline in dialysis bags
immersed in thioglycoilate broth. Cultures were
removed from the saline by centrifugation at 2000
rpm for 30 minutes, followed by Millipore filtra-
tion of the supernate. The filtrate was dialysed
against buffered physiologic saline for 48 hours
at 4° C and the protein content of the antigen
determined by the Kjcldahi nitrogen determina-
tion method (3). The concentrated antigen was
diluted to contain 1 mg of antigen protein/mi of
solution and dilutions of 1:10, 1:100 and 1:1000
were prepared from the stock antigen of 1 mg
protein/ml. Four tenths per cent phenol was
added to each dilution as preservative and the
antigens were sampled into 5 ml vials as described
previously. Saline controls for the disrupted antigen
consisted of buffered physiologic saline to which
phenol had been added, and for the diaiysatc
antigen, of buffered saline which had been im-
mersed in dialysis bags in thioglycollate broth
for 21 days, dialysed against buffered saline for 48
hours, Millipore filtered and to which 0.4% phenol
had been added. Preliminary toxicity studies of
both antigens were carried out in animals. Con-
centrated antigens were used for intradermal test-
ing in rabbits and guinea pigs. There were no
indications of untoward reactions with either
antigen at the lughest concentration.
Test subjects. A total of 766 intradermal tests
were carried out on 92 women. Forty-six of these
had varying degrees of acne and 46 were healthy
controls without acne. All women tested were in-
mates at the California Institution for Women
at Frontera, California, who volunteered for the
study. Their ages ranged frcm 49 years to 20 years,
the average age of the test group being 28 years
and for the control group, 31. There ware 9 Negroes
and 7 Mexicans in the test group and 10 Negroes
and 3 Mexicans in the control group. The rest
were Caucasian. Among the women in the test
group, 7 had pustular acne classified as Grade II
according to the grading system described by
Pillsbury, Shelly and Kligman (4). Seventeen had
Grade I acne, 12 had mild to moderate comedo-
papular acne with severe scarring and 10 had mild
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to moderate comedo-papular acne without scar-
ring.
For each subject, skin testing was started with
the highest dilutions of eacb antigen (i.e. 1:100,000
of disrupted and 1:1000 of dialysed antigens). If
the delayed hypersensitivity reactions were nega-
tive, the next lower dilutions (i.e., 1:10,000 of dis-
rupted and 1:100 of dialysed antigens) were used,
and so on until delayed hypersentitivity readings
became positive. No concentrations of antigen
greater than 1:1000 of disrupted and 1 mg/ml of
dialysed antigens were used.
The results of the skin tests were read for
immediate sensitivity 20 minutes after inoculation.
The grading of the immediate reaction was as
follows: 5 mm erythema, with no wheal—one plus;
erythema, wheal and flare but no pseudopods—
2 plus; erythema, wheal, flare and pseudopods—
three plus; erythema, wheal, flare, pseudopods and
induration over at least 30 mm—four plus.
Delayed hypersensitivity reactions were read
24 hours and 48 hours after inoculation. The de-
layed reactions were graded from one plus to three
plus. Five mm induration and erythema, was in-
terpreted as one plus; 10—20 mm interpreted as two
plus and 20 mm or more as three plus.
Serology. Ten ml of blood was obtained from
each subject at the beginning of the study prior to
skin testing. The sera were separated, divided into
1 ml amounts and stored frozen at 40 C. Antibody
titers to C. acnes were determined in all sera by
both the bacterial agglutination and complement
fixation tests; the techniques for these have been
described previously (1,2).
RESULTS
A. Delayed hypersensitivity to C. acnes:
The delayed hypersensitivity tests were car-
ried out with all four dilutions of each of
the two antigens. Results are presented in
Table II. With the high dilutions of antigen,
neither the acne group nor the control group
demonstrated significant delayed hypersensi-
tivity to the C. acnes antigens used in this
study. As the concentration of the antigen was
increased, the frequency of positive readings
was slightly increased; (i.e. with the dialysed
antigen at 1: 100 dilution, 20.9% (9/43) of the
acne group responded versus 9.1% (4/44) of
the controls). However, the difference in re-
sponse was not statistically significant, be-
tween the acne group and the control group
indicating that delayed hypersensitivity to C.
acnes can not be correlated with the presence of
acne vulgaris.
Only 16.6% of the delayed reactions were
positive for 48 hours. In most eases the ery-
thema and induration appeared within 16
A. Disrupted antigen* B. Dialysedantigen
First 1:100,000 1:1000
Second 1:10,000 1:100
Third 1:5000 1:10
Fourth 1:1000 1:0
* Gms of lyophilized disrupted C. acnes/mJ
buffered saline.
t Mg of antigen protein/ml buffered saline.
TABLE II
Delayed hypersensitivity to C. aenes antigens in
patients with acne and in controls
hours after inoculation and had faded by 48
hours. All the eases in which the delayed re-
action remained positive for 48 hours were
patients with acne.
B. Immediate sensitivity. Skin tests in the
control group indicated that the two highest
dilutions of each antigen, i.e. 1:100,000 and
1: 10,000 of the disrupted antigen and 1: 1000
and 1: 100 of the dialysed antigen, were the
most suitable concentrations for use in skin
testing for immediate hypersensitivity to C.
acnes. With higher concentrations of antigen
over 30% of the control subjects showed mild
positive reactions indicating that these were
probably reflections of inflammatory response
rather than true hypersensitivity.
Immediate sensitivity results are presented
in Table III. The results with the dialysed
antigen in particular demonstrate that patients
with acne show greater immediate sensitivity
to C. ocnes than patients without acne. Using
TABLE I
Dosages of skin testing antigen
Acne
No. Per-! ceotage
Cootcola
No. Pr
ceo?age
Antigen
Disrupted
Dialysed
Dosage
1
2
3
4
1
2
3
4
46
39
35
31
46
43
38
34
2
4
19
27
2
9
13
29
4.3
10.2
54.2
87.0
4.3
20.9
34.2
85.3
46
43
42
42
46
44
44
44
0
3
19
37
0
4
10
27
0
7.0
45.2
88.0
0
9.1
22.7
61.4
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TABLE III
Immediate sensitivity to C. acnes antigens in
patients with acne and in controls
Acne Controls
Antigen Dosage 3f No.'r1e Per-centage 32t No.t'; Per-centage
Disrupted 1
2
46
39
8
31
17.3
79.5
46
43
5
14
10.8
32.5
Dialysed 1
2
46
43
22
34
48.8
79.0
46
44
1
10
2.1
22.7
the highest dilution of antigen, 48.8% of the
acne patients showed immediate hypersensi-
tivity, while only 2.1% of the controls re-
sponded. When the antigen concentration was
increased 10 fold, 79.0% of the acne patients
responded, versus only 22.1% of the controls.
The disrupted antigen was not as satisfactory
for demonstrating immediate sensitivity. With
the highest dilution of disrupted antigen
17.3% of the acne group versus 10.8% of the
control group responded; and when the anti-
gen concentration was increased 10 fold, 79.5%
of the acne group versus 32.5% of the control
group showed an immediate hypersensitivity
response.
In Table III only immediate sensitivity re-
actions of two plus or higher were read as
positive. That is, only those with a true
wheal and flare response within 20 minutes
were included in the significantly positive
group readings. This was done to avoid pos-
sible misinterpretation of results due to very
weak or doubtful readings, as indicated by one
plus reactions.
If patients with acne were further cate-
gorized according to the severity of their dis-
ease, the group with severe scarring showed
the highest immediate sensitivity response.
C. Serology. Results of the serology tests arc
presented in Table IV. The average agglutinat-
ing antibody titer in the acne group was be-
tween 1:320 and 1:640, in the control group
between 1:40 and 1:80. The average comple-
ment-fixing antibody titer in the acne group
was 1:80, in the control group between 0 and
1:10. This finding correlates with our pre-
vious findings (1, 2) that antibody levels to
C. acne.s are higher in patients with acne
vulgaris than in controls without acne. How-
ever, there appears to he no clear cut cor-
relation between antibody levels to C. acnes
and immediate hypersensitivity to C. ocnes.
This is demonstrated in Table V and VI. The
results of immediate hypersensitivity tests to
C. ocnes antigens are compared to the bac-
terial agglutination (Table V) and comple-
ment fixation (Table VI) levels found in the
TABLE IV
Average ontibody titers to C. acnes in patients with
acne and in control group
Acne Controls
Agglutination titer 1:320—1:640 1:40—1:80
Complement-fixation
titer
1:80 0—1:10
TABLE V
Relationship between agglntinatiny antibody titers
to C. acnes and immediate sensitivity to
C. acocs
Agglutioating
titer 5trongposittve Doubttol Negativepositive Antigen used
40 or less 0 5 20 Disrupted
80—160 3 3 10
320—640 1 14 17
Over64O 7 8 4
40 or less 0 2 25 Dialyscd
80—160 3 3 9
320—640 9 10 13
Over 640 12 5 1
TABLE VI
Relationship between complement fixing antibody
titers to C. acnes ond immediate sensitivity
to C. nones
F.C. titer
20 or less
40—80
l60ormore
5teong
positive
3
3
5
Doubtful
positive
15
9
5
Negative
36
10
6
Antigen used
Disrupted
20 or less
40—80
l60ormore
———
2
13
10
————
14
2
3
38
6
4
—
Dialyscd
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sera of subjects tested. From these tables it
can be seen that although there are more strong
positive reactions to C. acnes antigens among
persons with high antibody titers to C. aenes
than among persons with low antibody titers,
the presence of high levels of antibody does
not always indicate the presence of strong
hypersensitivity reactions. Similarly strong
hypersensitivity reactions may occur in per-
sons with low antibody levels.
DISCUSSION
Bacterial allergy has been demonstrated as
a significant factor in certain skin diseases,
such as erythema nodosum, erythema multi-
forme, urticaria, (8—13). Investigations into
the role of staphylocoecal and streptocoecal
allergy in numerous skin diseases demonstrate
that the only undisputed proof of allergic
etiology of the disease is elicitation of the
dermatologic lesion in the patient by the in-
troduction of specific bacterial antigen (8).
This direct cause-effect relationship has been
demonstrated in certain eases, of urticaria, for
example. TJrticaria-like lesions can be elicited
in certain patients with urtiearia by the in-
troduction of staphylococeal polysaccharide
antigen (11). A second, more debatable proof
of allergic involvement in skin disease is the
demonstration of hypersensitivity by intra-
dermal testing. Strong hypersensitivity reac-
tions demonstrate the presence of bacterial
allergy but do not establish whether this is of
importance in the pathogenesis of the dis-
ease. In our work with C. ecnes antigens we
did not succeed in eliciting acne-like lesions
through intradermal inoculation of C. acnes
antigens in patients with acne vulgaris. We
did however produce evidence of allergic in-
volvement by demonstrating a strong degree of
immediate hypersensitivity to C. acnes anti-
gen in patients with acne vulgaris. Patients
with acne showed a much greater frequency of
immediate sensitivity to C. acnes than did
healthy controls without acne. This immediate
sensitivity was demonstrated against C. acnes
antigen, which contained extracellular metabolic
products of C. ocnes, but no whole organisms.
The fact that sensitivity to the disrupted antigen,
which contained fragments of the intact organ-
isms, was less marked than to the dialysed anti-
gen, may suggest that extracellular products of
C. acnes are capable of sensitizing the skin, and
penetration by the intact organism may not be
required.
Our results failed to demonstrate significant
differences in delayed hypersensitivity to C.
acnes between the test group with acne vulgaris
and the control group without acne.
There was little correlation between the
antibody levels to C. aenes and the strength of
immediate sensitivity reactions to C. acnes.
Some patients with bacterial agglutination
titers of 1:640 or higher, showed no sensitivity
to C. acne.s, while others with antibody titers
of less than 1:20 showed intense immediate
sensitivity. This parallels the results of
Rudzki et al, who in a study of immediate
sensitivity to streptocoecal antigen in patients
with skin diseases demonstrated that anti-strep-
tolysin titers could not be correlated with im-
mediate sensitivity reactions to streptolysin (9).
Although immediate sensitivity reactions appear
to be independent of antibody titers, generally
the patients with acne had a higher level of anti-
bodies to C. aenes and also a greater degree of
immediate sensitivity to C. aenes. This correla-
tion was most pronounced with the immediate
sensitivity to the dialysed antigen.
Although immediate sensitivity to C. czcnes
can be demonstrated in patients with acne, its
importance in the pathogenesis of acne is de-
batable. Olansky and Tully have described the
successful use of a C. acnes vaccine for hypo-
sensitization in the treatment of patients with
pustular and cystic acne (14). If indeed bac-
terial allergy is involved in acne vulgaris, this
would correlate well with the clinical finding
that corticosteroids are very effective for the
treatment of acne (15—19).
The fact that patients with severe scarring
had the greatest sensitivity in spite of the fact
that they had fewer active lesions, would in-
dicate that the hypersensitivity reaction is a
reflection on the degree of sensitization which
occurred during the active st.ages of acne. Those
with severe scarring had experienced the
severest forms of the disease and thus had the
greatest degree of sensitization. As has been
pointed out in other studies (13) on the role
of bacterial allergy in skin disease, sensitiza-
tion and infection may be interdependent var-
iables. The degree of infection determines the
amount of sensitization and once sensitiza-
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tion has occurred, it may in turn, affect the
progress of the infection.
Further studies are presently being carried
out to determinc the exact nature of the ex-
tracellular antigen from C. ocnes which ap-
peared to be the sensitizing factor in acne.
SUMMARY
Forty-six patients with varying degrees of
acne and 46 healthy controls without acne
were tested for immediate and delayed hyper-
sensitivity to two antigens prepared from
Corynebacterium acncs. The results were:
1. Patients with acne showed a marked de-
gree of immediate hypersensitivity to C. acnes.
2. Delayed hypersensitivity to C. acnes did
not appear to be increased in patients with
acne vulgaris.
3. Of the two antigens used for skin testing,
the antigen containing extracelhilar products of
C. acncs was meat effective in demonstrating hy-
persensitivity.
4. There was very little correlation between
antibody levels to C. acncs and the degree of
immediate or delayed hypersensitivity to C.
acncs antigens.
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